Home › Products › Diabetes › Poviztra 0.25mg FlexTouch
Poviztra 0.25mg FlexTouch
Salt Composition: SEMAGLUTIDE
- Manufacturer: ZUVENTUS HEALTHCARE LTD
- Pack Size: 1 PREFILLED PEN(s)
- Dosage Form: INJECTION
- Strength: 0.25MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store your pen in the fridge (not the freezer), it should be kept between 2°C and 8°C. If you forget a dose, take it within 5 days. If itâs been longer, skip that dose and stick to your regular schedule. Never take two doses at once to make up for a missed one. Signs of overdose (like severe nausea or vomiting) need medical attention right away. Always keep the pen out of childrenâs reach and donât share it, even if the needle is changed.
₹7384.00₹8790.00
Inclusive of all taxes
Product Introduction
Poviztra 0.25mg FlexTouch is administered as a once-weekly injection for weight management in adults. The medicine contains semaglutide, a GLP-1 receptor agonist that acts similarly to a natural hormone involved in appetite and food intake regulation. By functioning as a GLP-1-based medicine, it promotes earlier satiety and sustained feelings of fullness, facilitating reduced food intake and selection of healthier dietary options. Poviztra 0.25mg FlexTouch is indicated for patients who are overweight or have obesity, particularly those with concurrent conditions including hypertension, type 2 diabetes, or hypercholesterolaemia. This is not a standalone solution but forms part of a comprehensive weight management programme incorporating balanced nutrition and consistent physical activity. Your doctor will review your medical history to establish whether Poviztra 0.25mg FlexTouch is appropriate for your weight management objectives prior to commencing therapy.
Uses
Poviztra 0.25mg FlexTouch uses are: Long-term weight management in adults with obesity (BMI of 30 or more) Weight management in adults with a BMI of 27 or more who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol
How it works
Poviztra 0.25mg FlexTouch supports weight loss by mimicking natural hormones that regulate hunger. As a GLP-1 medication, it sends signals to your brain that you are full, helping you feel satisfied after smaller meals. It also slows down the movement of food through your stomach, which prolongs fullness and reduces cravings. Poviztra 0.25mg FlexTouch influences GIP, another hormone involved in metabolism, which can help improve how your body handles nutrients and supports weight management. Using a GLP-based approach like Poviztra 0.25mg FlexTouch provides consistent appetite control over time. Results appear gradually, allowing you to eat less without feeling deprived, which is essential for sustainable, long-term weight loss.
Side Effects
Poviztra 0.25mg FlexTouch causes some side effects like all medications, although not everyone will experience them. Common side effects: Nausea Vomiting Constipation or diarrhoea Tiredness Headache Indigestion Bloating or gas Serious side effects (get medical help if you notice these): Severe stomach pain or signs of pancreatitis Gallbladder issues (like pain in your upper belly or yellowing of the skin) Signs of kidney problems (such as less urination or swelling) Fast heart rate Allergic reactions (rash, itching, swelling, trouble breathing)
References
- Novo Nordisk Inc, FDA Food and Drug Safety Administration [September 20, 2019] [Accessed date 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s032lbl.pdf
- Novo Nordisk Limited, EMC, [25 Jan 2023], [Accessed date 18th August 2023] Electronic Medicines Compendium (EMC), [Revised on 25th Jan 2023] [Accessed on 18 August 2023] https://www.ema.europa.eu/en/documents/overview/ozempic-epar-summary-public_en.pdf
- https://cdscoonline.gov.in/CDSCO/cdscoDrugs
Safety Advice
Pregnancy: Unsafe Poviztra 0.25mg FlexTouch is not safe during pregnancy. If you're planning to get pregnant, you'll need to stop this medication at least 2 months before trying.
Lungs: Consult Your Doctor Poviztra 0.25mg FlexTouch doesnât directly affect your lungs. If you have asthma or another lung issue, itâs still safe, but your doctor should be in the loop.
Breastfeeding: Consult Your Doctor If you are breastfeeding, consult your healthcare provider before using Poviztra 0.25mg FlexTouch, as its efficacy and safety in breastfeeding are unknown.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.